Skip to main content
. 2021 Sep 8;22(5):1278. doi: 10.3892/etm.2021.10713

Figure 3.

Figure 3

miR-122-5p mimic further promotes LPS-treated acute lung injury cell injury. (A) RT-qPCR analysis of miR-122-5p expression in A549 cells transfected with mimic control or miR-122-5p mimic for 24 h. (B) RT-qPCR analysis of miR-122-5p expression in A549 cells in the different groups. (C) MTT assay of cell viability in the different groups. (D) LDH release analysis in the different groups of cells. (E) Flow cytometry analysis of apoptosis and (F) the apoptotic ratio. (G) Western blotting of cleaved-caspase 3 protein expression and the (H) cleaved-caspase 3/caspase 3 ratio. **P<0.01 vs. mimic control; ##P<0.01 vs. control; &&P<0.01 vs. LPS + mimic control. miR, microRNA; LPS, lipopolysaccharide; RT-qPCR, reverse transcription-quantitative PCR; LDH, lactate dehydrogenase.